# FDA Inspection 655817 - Delta Blood Bank - March 15, 2010

Source: https://www.keypedia.com/records/fda_inspections/delta-blood-bank/0ee90601-3216-463f-9bce-5e0b7487bc6a
Source feed: FDA_Inspections

> FDA Inspection 655817 for Delta Blood Bank on March 15, 2010. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 655817
- Company Name: Delta Blood Bank
- Inspection Date: 2010-03-15
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 967026 - 2016-02-29](https://www.keypedia.com/records/fda_inspections/delta-blood-bank/ba7412da-727f-4566-9d16-7eeb0ba554e9)
- [FDA Inspection 876444 - 2014-04-28](https://www.keypedia.com/records/fda_inspections/delta-blood-bank/2dec8e5c-a507-4f96-9fc1-104eaa8924ec)
- [FDA Inspection 752453 - 2011-11-07](https://www.keypedia.com/records/fda_inspections/delta-blood-bank/88960e45-16a8-49fb-97ee-96d92788fcfe)

Company: https://www.keypedia.com/companies/delta-blood-bank/4bee3556-183d-4959-91de-bb65015c0de8

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d